About this trial

The study aims to assess whether the transverse diameter of the right common femoral vein (RCFV) in the inguinal region could reflect the degree of post-spinal hypotension during elective orthopedic surgery.

Eligibility criteria

Qualifiers

Age > 60 years.

American Society of Anesthesiologists (ASA) physical state I-II.

Body mass index (BMI) ≤35 kg/m². Patients above this value will be excluded because obesity may cause technical difficulty and poor image quality in femoral vein ultrasound assessment.

Elective lower-limb orthopedic surgery under spinal anesthesia.

Disqualifiers

Patients refusing to participate.

History of psychiatric illness or seizures.

Absolute contraindications to spinal anesthesia: infection at the puncture site, severe coagulopathy/anticoagulation [defined as platelet count <75,000/µL, International Normalized Ratio (INR) >1.5, Activated Partial Thromboplastin Time (aPTT) >1.5 times control, or the use of anticoagulants such as warfarin, heparin, low molecular weight heparin, or direct oral anticoagulants within the recommended safety interval for neuraxial anesthesia], severe hypovolemia, increased intracranial pressure, or known allergy to local anesthetics.

Severe cardiac disease, including left ventricular ejection fraction <30%, Severe valvular heart disease (e.g., critical aortic stenosis), clinically significant arrhythmias (atrial fibrillation with uncontrolled ventricular rate >120 bpm, frequent ventricular ectopy or sustained ventricular tachyarrhythmia) and congestive heart failure such as New York Heart Association (NYHA) class III-IV.

Trial design

Treatments tested in this trial

  • Measurement of Femoral Vein Diameter

Treatment groups

43 Participants
are divided into 1 treatment group

Locations

1
Cairo University12613, Cairo Egypt

Sponsors and collaborators

Cairo University

Lead sponsor